GNH USA

Europe — EMA

Palexia (Tapentadol)

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a unknown/unknown for oral use. It treats moderate to severe acute pain and chronic pain in adult patients.

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

1
Pack/s

What is Tapentadol?

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a unknown/unknown for oral use. It treats moderate to severe acute pain and chronic pain in adult patients. GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tapentadol used for?

Palexia is an opioid analgesic that operates  through          ​                                                                                             

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Tapentadol
Route
Oral Use
Manufacturer
Grünenthal Gmbh
Origin
EU

Related products